论文部分内容阅读
比较了接种原配方（含百日咳菌４５亿／ｍｌ）和新配方（９０亿／ｍｌ）吸附百白破混合制剂（ＤＰＴ）后的接种反应和抗体动态。结果证明，新配方制剂能在基础免疫和加强免疫后至少１年内增强抗体的应答反应，提高免疫效果，而且不加重接种后的发热反应和局部中强反应。
The inoculation reaction and antibody dynamics after inoculation of DPT with the original formula (4.5 B / ml) and the new formulation (9 B / mL) were compared. The results show that the new formulation can enhance the antibody response and enhance the immune effect at least one year after the basal and booster immunizations, and does not aggravate the post-vaccination fever and local moderate reactions.